Jan Schnitzer

Proteogenomics Research Institute for Systems Medicine (PRISM)

BIOGRAPHY

Jan Schnitzer is the CEO and Founder of the Proteogenomics Research Institute for Systems Medicine, having devoted more than 30 years to understanding vascular endothelial cell barrier function and drug delivery. His research focuses on overcoming biological barriers to improve the therapeutic impacts of drugs in cancer, lung, and other diseases.

Jan's work spans drug delivery systems, proteomic mapping of endothelial cell surfaces, caveolae transport, antibody engineering, nanocarriers, and the development of new therapeutics in cancer and lung disease.